Hence, based on that crystal structure, we took a virtual screening approach to identify commercially available drug-like molecules that may act similarly to FR159, and we tested a number of them in human pancreatic tumor BxPC-3 cells expressing both E-cadherin and P-cadherin, which would allow us to probe, selectively, modulation of cadherin function. Here, CDH1 is linked to pancreatic neoplasm.